Skip to main content
Premium Trial:

Request an Annual Quote

DNAPrint, NeoCodex Pen Pharmacogenomic Alliance Into Ovarian Cancer

NEW YORK (GenomeWeb News) – DNAPrint Genomics today said it and a Spanish biotech will try to identify genes linked to how individuals with ovarian cancer respond to certain chemotherapeutic agents.
 
Terms of the deal call for DNAPrint to test DNA samples collected by NeoCodex of Seville to study “the effectiveness of certain treatments for ovarian cancer” involving Taxotere, Taxol, Carboplatin, and Cisplatin.
 
DNAPrint said it will use its admixture mapping process “to identify appropriate ancestry informative markers within the targeted population to identify genes of further interest, based on the drug response data provided by NeoCodex.”
 
Financial details of the agreement were not disclosed.

The Scan

Single-Cell Sequencing Points to Embryo Mosaicism

Mosaicism may affect preimplantation genetic tests for aneuploidy, a single-cell sequencing-based analysis of almost three dozen embryos in PLOS Genetics finds.

Rett Syndrome Mouse Model Study Points to RNA Editing Possibilities

Investigators targeted MECP2 in mutant mouse models of Rett syndrome, showing in PNAS that they could restore its expression and dial down symptoms.

Investigators Find Shared, Distinct Genetic Contributors to Childhood Hodgkin Lymphoma

An association study in JAMA Network Open uncovers risk variants within and beyond the human leukocyte antigen locus.

Transcriptomic, Epigenetic Study Appears to Explain Anti-Viral Effects of TB Vaccine

Researchers report in Science Advances on an interferon signature and long-term shifts in monocyte cell DNA methylation in Bacille Calmette-Guérin-vaccinated infant samples.